Simplex Trading
HBIO icon

Simplex Trading’s Harvard Bioscience HBIO Stock Holding History

Simplex Trading’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,379
Closed -$9.22K – 9496
2025
Q4 		$9.22K Buy
1,379
+1,104
+401% +$6.55K ﹤0.01% 7037
2025
Q3 		$1K Buy
+275
New +$1.3K ﹤0.01% 8814
2025
Q2 		– Sell
-410
Closed -$1.71K – 9075
2025
Q1 		$2K Sell
410
-258
-39% -$3.3K ﹤0.01% 7992
2024
Q4 		$14K Buy
668
+347
+108% +$7.97K ﹤0.01% 6947
2024
Q3 		$8K Buy
321
+104
+48% +$3.06K ﹤0.01% 7325
2024
Q2 		$6K Buy
217
+207
+2,070% +$7.26K ﹤0.01% 7766
2024
Q1 		$0 Sell
10
-115
-92% -$5.17K ﹤0.01% 9246
2023
Q4 		$6K Buy
125
+28
+29% +$1.26K ﹤0.01% 7754
2023
Q3 		$4K Buy
+97
New +$4.48K ﹤0.01% 7765
2023
Q1 		– Sell
-10
Closed – – 9441
2022
Q4 		$0 Sell
10
-140
-93% -$3.45K ﹤0.01% 9653
2022
Q3 		$3K Buy
150
+126
+525% +$4.17K ﹤0.01% 9088
2022
Q2 		$0 Buy
+24
New +$1.08K ﹤0.01% 10387
2022
Q1 		– Sell
-166
Closed -$9.82K – 10780
2021
Q4 		$11K Buy
+166
New +$11.8K ﹤0.01% 8934
2020
Q4 		– Sell
-71
Closed -$2.65K – 8613
2020
Q3 		$2K Buy
+71
New +$2.39K ﹤0.01% 7415
2018
Q4 		– Sell
-559
Closed -$29K – 7310
2018
Q3 		$29K Buy
+559
New +$31.4K ﹤0.01% 5669
2017
Q4 		– Sell
-14
Closed – – 6240
2017
Q3 		$0 Buy
+14
New +$414 ﹤0.01% 6169

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's HBIO Position: Q1 2026 in Review

Simplex Trading sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 1,379 shares — an estimated $9.22K sold.

Simplex Trading first reported a position in HBIO in Q3 2017 and held it in 16 quarters. The position peaked at $29K in Q3 2018. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Simplex Trading reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,379 Harvard Bioscience shares in Q1 2026, an estimated $9.22K.
  • Simplex Trading first reported a position in Harvard Bioscience in Q3 2017 and held it in 16 quarters.
  • Simplex Trading's Harvard Bioscience position peaked at $29K in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.